Literature DB >> 18547532

Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice.

Setty Balakrishnan Anand1, Vadivel Murugan, Prince Rajaiah Prabhu, Veerabhadran Anandharaman, Maryada Venkata Rami Reddy, Perumal Kaliraj.   

Abstract

Although DNA vaccines have several advantages over conventional vaccines, antibody production and protection are often not adequate, particularly in single plasmid vaccine formulation. In the present study we evaluated the efficacy of a cocktail vaccine based on plasmids encoding larval (L3) stage-specific Brugia malayi abundant larval transcript (BmALT-2) and antioxidant detoxification enzyme B. malayi thioredoxin peroxidase (BmTPX) to induce antibodies, protective efficacy and cell-mediated immune response in mice. Mice immunized with cocktail DNA vaccines containing the pVAX ALT-2+TPX developed higher titers of anti-BmALT-2+TPX (1:5000) antibodies, compared to the mice immunized with single DNA vaccine of pVAX ALT-2 or pVAX TPX (1:2000). Correlating with this, the mice administered with cocktail vaccine induced up to 78% of cytotoxicity against B. malayi mf. This cytotoxicity was high compared to 34% induced by the pVAX-ALT2 or 37% by pVAX-TPX. Moreover, cocktail vaccination of mice resulted in significantly higher level of cellular proliferative response associated with raised levels of IFN-gamma that skewed towards Th1 type of response compared to vaccination using either of the components. Taken together, these data suggest that the combination of two or more antigens maybe an effective vaccine development strategy to improve protection and immunogenicity against human lymphatic filariasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547532     DOI: 10.1016/j.actatropica.2008.04.018

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  18 in total

Review 1.  Peroxiredoxins in parasites.

Authors:  Michael C Gretes; Leslie B Poole; P Andrew Karplus
Journal:  Antioxid Redox Signal       Date:  2012-01-25       Impact factor: 8.401

2.  Granuloma formation around filarial larvae triggered by host responses to an excretory/secretory antigen.

Authors:  Yashodhara Dash; Manish Ramesh; Ramaswamy Kalyanasundaram; Gnanasekar Munirathinam; Leonard D Shultz; T V Rajan
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

Review 3.  A comprehensive, model-based review of vaccine and repeat infection trials for filariasis.

Authors:  C Paul Morris; Holly Evans; Sasha E Larsen; Edward Mitre
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

4.  Immunogenicity of Brugia malayi Abundant Larval Transcript-2, a potential filarial vaccine candidate expressed in tobacco.

Authors:  Mathangi Ganapathy; Adhiseshan Perumal; Chakravarthi Mohan; Harunipriya Palaniswamy; Kaliraj Perumal
Journal:  Plant Cell Rep       Date:  2013-11-07       Impact factor: 4.570

5.  Prospects of developing a prophylactic vaccine against human lymphatic filariasis - evaluation of protection in non-human primates.

Authors:  Vishal Khatri; Nikhil Chauhan; Kanchan Vishnoi; Agneta von Gegerfelt; Courtney Gittens; Ramaswamy Kalyanasundaram
Journal:  Int J Parasitol       Date:  2018-06-06       Impact factor: 3.981

6.  Production and single-step purification of Brugia malayi abundant larval transcript (ALT-2) using hydrophobic interaction chromatography.

Authors:  Surianarayanan Bhuvanesh; Chakkaravarthi Arunkumar; Perumal Kaliraj; Subramanian Ramalingam
Journal:  J Ind Microbiol Biotechnol       Date:  2010-07-01       Impact factor: 3.346

7.  Immunization with Wuchereria bancrofti Glutathione-S-transferase Elicits a Mixed Th1/Th2 Type of Protective Immune Response Against Filarial Infection in Mastomys.

Authors:  Dhananjay Andure; Kiran Pote; Vishal Khatri; Nitin Amdare; Ramchandra Padalkar; Maryada Venkata Rami Reddy
Journal:  Indian J Clin Biochem       Date:  2016-02-09

8.  Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis.

Authors:  Nikhil Chauhan; Priyankana Banerjee; Vishal K Khatri; Andrew Canciamille; Jessica Gilles; Ramaswamy Kalyanasundaram
Journal:  Parasitol Res       Date:  2017-08-21       Impact factor: 2.289

9.  Protective immune responses to biolistic DNA vaccination of Brugia malayi abundant larval transcript-2.

Authors:  S K Joseph; S Sambanthamoorthy; G Dakshinamoorthy; G Munirathinam; K Ramaswamy
Journal:  Vaccine       Date:  2012-08-08       Impact factor: 3.641

10.  Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis.

Authors:  S K Joseph; K Ramaswamy
Journal:  Vaccine       Date:  2013-06-02       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.